BSEBoard Meeting4d ago · 11 Aug 2026, 02:38 pm
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange ....
Lactose India Ltd · 524202
✦ AI SummaryResults
Lactose India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 4,696.84 lakhs and net profit after tax at Rs. 236.56 lakhs.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lactose India Ltd - 524202 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August, 2026
Attachments (1)
📄pdf
Download →
9b061f0d-0715-4a1f-b293-af3d0fe683c2.pdf
View document text
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai‐ 400001
Scrip code‐ 524202
Subject: Outcome of Board Meeting.
Dear Sir,
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform
to the Exchange that the Board of Directors of the Company at their meeting held on
Tuesday, 11th August 2026 has, inter alia, considered and approved the followings
items of agenda:
1. Un‐audited Financial Results along with the Limited Review Report issued by the
Statutory Auditor of the Company for the first quarter ended 30th June, 2026.
The Meeting of the Board of Directors of the Company commenced at 12:00 Noon and
concluded at 02:15 P.M.
Kindly take the same on record and oblige.
FOR LACTOSE (INDIA) LIMITED
Atul Maheshwari
Managing Director
DIN: 00255202
Date: 11th August, 2026
Place: Mumbai
Encl: As above
Independent Auditor's Review Report on the Quarterly Unaudited Financial Results of the
Lactose (INDIA) Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended.
THE BOARD OF DIRECTORS,
Lactose (INDIA) Limited
1. We have reviewed the accompanying statement of unaudited Ind AS financial results of Lactose
(INDIA) Limited (“the Company”) for the Quarter ended 30th June 2026 being submitted by the
Company in pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulation 2015 (“the Listing Regulations”).
2. This statement, which is the responsibility of the Company's Management and approved by the
Board of Directors, has been prepared in accordance with the recognition and measurement
principles laid down in Indian Accounting Standards (IND AS) 34, “Interim Financial Reporting”
prescribed under section 133 of the Companies Act 2013 read with relevant rules issued
thereunder and accounting principles generally accepted in India and in compliance with
Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the
Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review
Engagements ('SRE') 2410, 'Review of Interim Financial Information Performed by the
Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India.
This standard requires that we plan and perform the review to obtain moderate assurance as
to whether the Statement is free of material misstatement. A review is limited primarily to
inquiries of company personnel and analytical procedures applied to financial data and thus
provides less assurance than an audit. We have not performed an audit and accordingly, we do
not express an audit opinion.
4. Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of unaudited financial results prepared in accordance
with applicable Indian Accounting Standards and accounting principles generally accepted in
India, has not disclosed the information required to be disclosed in terms of Regulation 33 of
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the
manner in which it is to be disclosed, or that it contains any material misstatement.
For D M K H & Co.
Chartered Accountants
Firm Registration No.: 116886W
CA Shikha Kabra
Partner
Membership No. 179437
UDIN: 26179437CHPWUE5297
Place: Mumbai
Date: 11th August 2026
I NDIA LI MITE D
LACTOSE(INDIA)LIMITED
CIN:L15201GJ1991PLC015186
Regd.Off. :SurveyNo.5,6&7A,VillagePoicha(Rania),TalukaSavli,DistrictVadodara,Gujarat-391780.
website:-www.Iactoseindialimited.com,EmailID:Iil@lactoseindialimited.com,Telephone:022-46644333
StatementofUnAuditedFinancialResultsfortheQuarter ended30thJune2026
(Rs.InLakhsExceptforEPS)
QuarterEnded
Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26
UnAudited Audited UnAudit I I G.I
Revenuefromoperations
Revenuefromoperations 4,696.84 4,576.61 3,957.56 16,329.01
OtherIncome 55.98 41.46
21.54 107.18
Totalincome
4,752.82 4,598.15 3,999.02 16,436.20
Expenses
(a)Costofmaterialsconsumed 3,249.18
2,828.28 1,563.63 8,752.02
(b)Changeininventoriesoffinishedgoods work-in-progress
andstock-in-trade (613.46) (104.21) 676.67
763.82
(c)ManufacturingExpenses 785.70 655.94 2,553.86
617.57
(d)Employeesbenefitsexpenses 421.29 353.01
343.58 1,407.83
(e)FinanceCosts 176.41 142.97 508.60
122.01
(f)Depreciationandamortizationexpenses 163.76 150.09 574.22
137.28
(g)Otherexpenses 246.63 341.18 1,100.99
222.26
TotalExpenses 4,429.51 4,367.27 3,770.15 15,574.18
3 Profit/(Loss)beforetax
323.32 230.89 228.87 862.01
Exceptionalitems
Profitbeforetax
323.32 230.89 228.87 862.01
4TaxExpense:
CurrentTa(net)
67.60 38.54 38.20 143.89
DeferredTax(net)
19.16 26.79 40.81 133.97
TaofEarlierYears
(22.13 (22.13
5 NetProfit/(Ioss)aftertax
236.56 187.69 149.86 606.28
6 OtherComprehensivelncomel(Ioss)
ItemsThatwillnotbereclassifiedsubsequentlyinto
Profitorloss
Remeasurementofpostemploymentbenefitobligation 5.11 (1.82)
IncomeTaeffectonabove (1.42 0.51
7 TotalComprehensiveincome/(Ioss),netoftax (5+6)
236.56 191.38 149.86 604.97
Paid-upequitysharecapital(FaceValueofRs.10each) 1,258,90 1,258.90
1,258.90 1,258.90
9 OtherEquity(excludlngrevaluationreserve) • 5,220.03
10 amingspershare (ofRs.101-each)
notannualisedforthequarters) * L4`\
a)Basic(inRs.) A c
91 n 1.88 1.49 1.19 4.82
b)Diluted(inRs.) ' (YIN"\ 1.88 1.45 1.16 4.68
103-104,FirstFloor,"A"Wing,NavbharatEstate,ZakariaBunderRoad,Sewri(W),Mumbai-400015,India,
Tel.:+91-22-46644333Email : lil@lactoseindialimited.com Website:www.lactoseindialimited.com
Regd.Office -SurveyNo. 5,6&7A,Village: Poicha(Rania),TalukaSavli, District:Vadodara,Gujarat-391780, India. TWII\¢l9l1vahl.H
CIN : Ll520lGJl99lpLcol5186
LACT SE
I N DIA LI M ITED
LACTOSE(INDIA)LIMITED
CIN:L15201GJ1991PLC015186
Regd.Off.:SurveyNo.5,6&7A,VillagePoicha(Rania),TalukaSavli,DistrictVadodara,Gujarat-391780.
website:-www.Iactoseindialimited.com,EmailID:Iil@lac:toseindialimited.com,Telephone:02246644333
StatementofUnAuditedFinancialResultsfortheQuarter ended30thJune2026
Notes:
1 TheaboveFinancialResultswerereviewedbytheAuditCommitteeandthereafterapprovedandtakenonrecordbytheBoardofDirectors
attheirmeeting heldon nthAugust,2026.TheStatutoryAuditorsoftheCompanyhavecarriedoutlimitedreviewoftheaboveFinancial
ResultspursuanttoRegulation33oftheSEBI(ListingObligations&DisclosureRequirements)Regulations,2015.
2 TheCompanyoperatesinonereportablebusinesssegmenti.e.'Pharmaceuticals".
3 IntermsofSEBI(IssueofCapitalandDisclosureRequirements)Regulations,2018,theCompanyupontheshareholdersapprovals,hason
05th December2024,issuedandallotted15,00,000Convertiblesharewarrants,ataissuepriceofRs. 174per Convertiblesharewarrants,
25% ofwhich amounting to Rs. 652.50 Lacs had received bytheCompanyfrom the respective Allottee'stowards subscription amount.
Thesewarrants will be convertibleinto an equivalent number of Equity Shares offacevalue Rs.10 each at premium ofRs.164, in the
Company,uponreceiptofbalanceissueprice,withinaperiodofeighteenmonthsfromthedateofallotment.
Duringthequarterended30June2026,theperiodavailableforexercisingthesharewarrantsissuedbytheCompanyonapreferentialbasis
expiredon5thJune2026.Thewarrantholdersdidnotexercisetheiroptionbyremittingthebalance75%ofthewarrantexercisepricewithin
thestipulatedperiodprescribedunderthetermsofissueandtheapplicableSEBlregulations.
Accordingly, the Board of Directors, at its meeting held on 18th June 2026 , approved the forfeiture of such unexercised warrants.
Consequently,theupfrontamountof ?652.50 lakhs (being25% ofthewarrantissueprice) received atthetimeofallotmentofthesaid
warrants has been forfeited and transferred to Capital Reserve in accordance with the terms of issue and the applicable regulatory
requirements.
4 TheBoardofDirectors,atitsmeetingheldon23rdOctober2024,hadapprovedtheSchemeofArrangement("theScheme')formergerwith
Vitanosh Ingredient
[Showing first 8,000 characters — download PDF for full document]